JPRN-jRCT2031210404招募中未知
General use-results survey of Alunbrig Tablets Non-small cell lung cancer
Contact for Clinical Trial Information0 个研究点目标入组 500 人开始时间: 2021年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Participants with unresectable advanced/recurrent ALK fusion gene-positive non-small cell lung cancer.
排除标准
- •Participants who has a history of hypersensitivity to any component of brigatinib.
研究者
相似试验
招募中
Unknown
Intuniv Tablets drug use-results survey (Surveillance regarding pediatric use)Attention Deficit/Hyperactivity DisorderJPRN-jRCT1080223870SHIONOGI & CO., LTD.75
招募中
不适用
Special use-results survey of ENAROY Tablets(long-term use)Anemia associated with CKDJPRN-jRCT2031210549Patient Safety and Pharmacovigilance Dept.1,500
已完成
不适用
Evaluation of effect of Glubes combination tablet on the HbA1c levels and vascular endothelial functiotype 2 diabetes mellitusJPRN-UMIN000008332The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University16
进行中（未招募）
不适用
Special drug-use survey of Tarlige tablet (evaluation of safety in long-term use)JPRN-jRCT2031200212Matsuoka Yomei900
已完成
不适用
Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"Type 2 Diabetes MellitusNCT02221284Takeda964